[SRNE] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
09-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- 38.49%
YoY- 68.44%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 9,007 6,477 3,913 4,665 902 1,173 775 50.44%
PBT -82,213 -70,654 -74,081 -16,137 -46,113 -10,975 -8,454 46.04%
Tax -1,919 -383 -1,377 -1,398 -1,164 -17 5 -
NP -77,740 -56,762 -73,864 -14,187 -44,949 -10,958 -8,454 44.69%
Tax Rate - - - - - - - -
Total Cost 86,747 63,239 77,777 18,852 45,851 12,131 9,229 45.22%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin -863.11 -876.36 -1,887.66 -304.12 -4,983.26 -934.19 -1,090.84 -3.82%
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS -0.36 -0.46 -0.73 -0.20 -0.97 -0.30 -0.33 1.45%
EPS Diluted -0.36 -0.43 -0.73 -0.20 -0.97 -0.30 -0.33 1.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.